Answer
Women of childbearing potential should use effective contraception throughout tebentafusp treatment and for at least 1 week after the last dose.
Sources for this answer
- KIMMTRAK (tebentafusp) 200 micrograms/ mL concentrate for solution for infusionImmunocore Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 1Document updated
Sources checked